BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10800166)

  • 1. Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
    Camera A; Pezzullo L; Villa MR; Luciano L; Pane F; Izzo B; Boccuni P; Di Noto R; Del Vecchio L; Salvatore F; Rotoli B
    Haematologica; 2000 May; 85(5):496-501. PubMed ID: 10800166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest.
    Tordjman R; Macintyre E; Emile JF; Valensi F; Ribrag V; Burtin ML; Varet B; Brousse N; Hermine O
    Leukemia; 1996 Sep; 10(9):1514-9. PubMed ID: 8751472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
    Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
    Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
    Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
    Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor gammadelta-large granular lymphocytic leukemia associated with an aberrant phenotype and TCR-Vbeta20 clonality.
    Vartholomatos G; Alymara V; Dova L; Kolaitis N; Bourantas KL
    Haematologica; 2004 May; 89(5):ECR16. PubMed ID: 15136245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.
    Khan WA; Yu L; Eisenbrey AB; Crisan D; al Saadi A; Davis BH; Hankin RC; Mattson JC
    Am J Clin Pathol; 2001 Jul; 116(1):41-50. PubMed ID: 11447750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
    Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
    Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
    Koyama T
    Rinsho Byori; 2001 Mar; Suppl 115():140-3. PubMed ID: 11391932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
    Tai YC; Kim LH; Peh SC
    Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls.
    Kapur LH; Khaled Y; Solh M; Ward D; Chang CC
    Arch Pathol Lab Med; 2014 Jul; 138(7):969-73. PubMed ID: 24978925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.